Markets:

Overview

News

Currencies

International

Treasuries

Alvotech - Ordinary Shares (NQ:ALVO)

4.140 -0.180 (-4.17%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Alvotech - Ordinary Shares

< Previous 1 2 3 4 Next >

Earnings Scheduled For March 26, 2025 ↗

March 26, 2025

Via Benzinga

Alvotech Strengthens Biosimilar Portfolio With $27 Million Xbrane R&D Deal ↗

March 20, 2025

Alvotech acquires Xbrane's R&D operations and biosimilar candidate for SEK 275 million, enhancing development capabilities and expanding into Sweden.

Via Benzinga

Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket ↗

January 28, 2025

Via Benzinga

Earnings Scheduled For November 13, 2024 ↗

November 13, 2024

Via Benzinga

Alvotech's Earnings Outlook ↗

November 12, 2024

Via Benzinga

ALVO Stock Earnings: Alvotech Misses Revenue for Q2 2024 ↗

August 15, 2024

ALVO stock results show that Alvotech missed on revenue for the second quarter of 2024.

Via InvestorPlace

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

Alvotech's Earnings Outlook ↗

May 06, 2025

Via Benzinga

Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday? ↗

May 05, 2025

FDA approves Teva and Alvotech's Selarsdi as an interchangeable biosimilar to Stelara, supporting the treatment of multiple chronic inflammatory diseases.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 26, 2025

Via Benzinga

ALVO Stock Earnings: Alvotech Reported Results for Q4 2023 ↗

March 20, 2024

Alvotech just reported results for the fourth quarter of 2023.

Via InvestorPlace

Alvotech's Earnings: A Preview ↗

March 19, 2024

Via Benzinga

Alvotech's Earnings: A Preview ↗

November 27, 2023

Via Benzinga

JB Hunt Transport Posts Weak Earnings, Joins JetBlue Airways And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

January 17, 2025

Via Benzinga

Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket ↗

January 17, 2025

Via Benzinga

Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

January 15, 2025

Via Benzinga

UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars ↗

September 11, 2024

UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs.

Via Benzinga

Vipshop, Hesai Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

August 20, 2024

Via Benzinga

ALVO Stock Earnings: Alvotech Misses EPS for Q1 2024 ↗

May 21, 2024

ALVO stock results show that Alvotech missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Stocks Hold Steady On Mixed Fed Remarks, First Solar Rallies, Bitcoin Falls Below $70,000: What's Driving Markets Tuesday? ↗

May 21, 2024

It’s a rather quiet session on Tuesday, with major U.S. averages trading around the flatline at midday trading in New York.

Via Benzinga

Topics Economy

Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday ↗

April 19, 2024

Via Benzinga

Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday ↗

March 25, 2024

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

Via Benzinga

Topics Stocks

Earnings Scheduled For March 20, 2024 ↗

March 20, 2024

Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million.

Via Benzinga

TEVA Stock Pops 4% as Teva Receives FDA Approval ↗

February 26, 2024

Teva Pharmaceutical stock is rising higher on Monday after partner company Alvotech got approval from the FDA for a Humira biosimilar.

Via InvestorPlace

Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today? ↗

February 26, 2024

FDA-approved Simlandi (adalimumab-ryvk): a high-concentration biosimilar to Humira for rheumatoid arthritis, psoriasis, and more.

Via Benzinga

American Airlines To Rally Around 32%? Here Are 10 Top Analyst Forecasts For Monday ↗

January 29, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 19, 2024

Via Benzinga

Earnings Scheduled For November 28, 2023 ↗

November 28, 2023

Companies Reporting Before The Bell • Elbit Systems (NASDAQ:ESLT) is projected to report quarterly earnings at $1.70 per share on revenue of $1.45 billion.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2023 ↗

October 20, 2023

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Alvotech - Ordinary Shares (NQ:ALVO)

Headline News about Alvotech - Ordinary Shares

Starting at $3.75/week.

Subscribe Today